Jacques Rachelle Suzanne, a director at uniQure N.V. ($QURE), made one open market sale of common shares in the last 365 days, totaling $30,518. Her most recent $QURE insider sale occurred on June 20, 2025. This ranks her 10,805th among 11,678 individual insiders by sale value, well below the average of $8.6 million per insider and 6.4 transactions. She reported no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| June 20, 2025 | uniQure N.V. | $QURE | Jacques Rachelle Suzanne | Director | S | Ordinary Shares | 2112 | $14.45 | 28,346.0000 | 53,110,580 | 6.93% | 0.00% |
| June 11, 2025 | uniQure N.V. | $QURE | Jacques Rachelle Suzanne | Director | A | Stock Option (Right to Buy) | 15630 | $0.00 | 15,630.0000 | 53,110,580 | 9999.99% | 0.03% |
| June 11, 2025 | uniQure N.V. | $QURE | Jacques Rachelle Suzanne | Director | A | Ordinary Shares | 7970 | $0.00 | 30,458.0000 | 53,110,580 | 35.44% | 0.02% |
| May 30, 2025 | Corbus Pharmaceuticals Holdings, Inc. | $CRBP | Jacques Rachelle Suzanne | Not found | A | Stock options (right to buy) | 16000 | $0.00 | 16,000.0000 | 12,232,228 | 9999.99% | 0.13% |
| May 30, 2025 | Corbus Pharmaceuticals Holdings, Inc. | $CRBP | Jacques Rachelle Suzanne | Not found | A | Common Stock, par value $0.0001 per share | 4800 | $0.00 | 7,583.0000 | 12,232,228 | 172.48% | 0.04% |
| June 19, 2024 | uniQure N.V. | $QURE | Jacques Rachelle Suzanne | Director | A | Ordinary Shares | 8080 | $0.00 | 22,488.0000 | 48,384,510 | 56.08% | 0.02% |
| June 19, 2024 | uniQure N.V. | $QURE | Jacques Rachelle Suzanne | Director | A | Stock Option (Right to Buy) | 15840 | $0.00 | 15,840.0000 | 48,384,510 | 9999.99% | 0.03% |
| June 13, 2024 | uniQure N.V. | $QURE | Jacques Rachelle Suzanne | Director | S | Ordinary Shares | 2221 | $5.14 | 14,408.0000 | 48,384,510 | 13.36% | 0.00% |
| May 30, 2024 | Corbus Pharmaceuticals Holdings, Inc. | $CRBP | Jacques Rachelle Suzanne | Not found | A | Common Stock, par value $0.0001 per share | 2783 | $0.00 | 2,783.0000 | 0 | 9999.99% | 0.00% |
| May 16, 2024 | Corbus Pharmaceuticals Holdings, Inc. | $CRBP | Jacques Rachelle Suzanne | Director | A | Stock Option (right to buy) | 2783 | $0.00 | 2,783.0000 | 0 | 9999.99% | 0.00% |
| April 26, 2024 | Akari Therapeutics Plc | $AKTX | Jacques Rachelle Suzanne | Chief Executive Officer | A | Ordinary Shares, par value $0.0001 per share | 479569892 | $0.00 | 1,018,027,792.0000 | 0 | 89.06% | 0.00% |
| June 13, 2023 | uniQure N.V. | $QURE | Jacques Rachelle Suzanne | Director | A | Ordinary Shares | 8700 | $0.00 | 18,930.0000 | 47,436,335 | 85.04% | 0.02% |
| June 16, 2023 | uniQure N.V. | $QURE | Jacques Rachelle Suzanne | Director | S | Ordinary Shares | 2301 | $18.76 | 16,629.0000 | 47,436,335 | 12.16% | 0.00% |
| June 13, 2023 | uniQure N.V. | $QURE | Jacques Rachelle Suzanne | Director | A | Stock Option (Right to Buy) | 17060 | $0.00 | 17,060.0000 | 47,436,335 | 9999.99% | 0.04% |
| May 18, 2023 | Corbus Pharmaceuticals Holdings, Inc. | $CRBP | Jacques Rachelle Suzanne | Director | A | Stock Option (right to buy) | 5300 | $0.00 | 5,300.0000 | 0 | 9999.99% | 0.00% |
| Feb. 27, 2023 | uniQure N.V. | $QURE | Jacques Rachelle Suzanne | Director | S | Ordinary Shares | 384 | $20.02 | 10,230.0000 | 46,735,045 | 3.62% | 0.00% |